Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dude!!! We closed at 2.20! We're at 2.69 after market with bid at 2.50 and ask at 2.74 as of this message!!!
Beat me to it PennyPlayer!! IND filed for Iomab-b!!! Awesome news!
http://finance.yahoo.com/news/actinium-submits-iomab-b-ind-230000851.html
The 4th quarter 2015 8k will be the first full quarter reflecting rec sales.
Recreational sales began on October 1st.
The 2015 4th quarter financials will reflect recreational sales. Wouldn't care to answer the question until then.
I'll pay 15% tax on my shares when ready. If the pps is down I'll buy more. It's an opportunity. Great brick and mortar play with a low enough price to gamble. Boots on the ground. Unlike others.
Thankfully, some dilution but they've stayed away from a choke hold of toxic debt. If I ever see a filing with Magna's name on it.. I'm out. Look at inergetics chart for an example.
Buying and bullish.
Then you don't know the Magna Group and thankfully KAYS is smart enough to stay away from them.
http://www.bloomberg.com/news/articles/2015-03-12/josh-sason-made-millions-from-penny-stock-financing
Been long for a while now.
My plan exactly. They're growing the right way and still improving their outlook rapidly. Once the first 503B in Texas is finished in February and the 2nd 503B is completed in the 2nd quarter, I think the numbers will really pop and the balance sheet is going to even out and real value will be realized.
Water is gonna be choppy. It's volatile. Dollar cost average is the way to play long with unpredictable volatility. GL!
The Q actually beat analysts projections. Then there was a small hit piece that came out today by Louis Navellier.
Waiting for some of my other plays to take off and will buy more.
This will be volatile until the P/E ratio is positive.
This historically has tested 5 before. I thought it might do the same until the 503B facilities are operational.
I'll have to look into that story. It looks like they dumped their topical analgesic right around phase 3 trials a few years ago. Getting FDA approval on new treatments can break a company. The new pharmacy regulations are only about 2 years old.
Did you listen to the conference call?
Huh. Just checked the chart on this.
The split history is described in their 2014 10K:
https://www.sec.gov/Archives/edgar/data/1360214/000149315215000811/form10-k.htm
It's important to comb every detail and make a decision.
I'll correct myself here. I believe that Mr. Baum stated on the conference call the Texas 503B facility is projected to be operational in February 2016 and the New Jersey facility should be operational in Q2 2016.
Great conference call. Well done Mark Baum. If anyone missed it you can listen to the archive here:
http://www.investorcalendar.com/event/174457
The market sets the price and the market is always right. If the company continues to grow at the same pace pps will be reflected and rewarded. I believe they are still operating at a negative P/E ratio and the current market price is reflective of that. This company is still in its infancy and the story has years to play itself out.
If you check the yearly chart, I believe a trader will have plenty of opportunity to flip in the 9s and eventually in the 10s in the future. I think I posted before that there are some companies I will trade in and out of, but some companies I like because of the long potential. I'm cost averaging. I will say that my plan is not to sell my shares any time soon. If there is an acquisition years down the road, I don't have to worry about selling my shares on the market, nor concern myself with volume.
I'm on the ground floor and will keep IMMY as one of my growth stocks. I like their business model.
Only if one is trading. I'm investing.
I think it's going to look great next to Q3 2014.
IMMY is so new, the execution of their business plan really began in 2014. In 2015 they began acquiring pharmacies to launch their proprietary treatments and it sounds like their dropless eye therapy is really the clean up hitter for them.
2015 you can see real growth in their numbers - quarter to quarter - but they did acquire 3 pharmacies in September. Acquisitions could reflect negatively on a report but that's ok.
They forecasted better earnings for their urology treatment and stated their sales goals are about 60 days behind. That's why I think Q4, Q1 2016 are going to be really good.
Then the 2 new 503B compounding pharmacies will be reflected in Q2 2016 reports, barring any setbacks, I believe.
Just read they will be issuing quarterly earnings tomorrow.
Nope. Quarterly report time. Why is volume a concern?
"Ethical Capitalism" CNN Money posted a nice interview with CEO Mark Baum today.
There is a great video with shots of one of their compounding pharmacy operations.
Certainly looks that way. 3.6k shares right out of the gate.
I am too. Any good student of the market is still learning. There is always something it will teach you.
If I'm riding high and thumping my chest and riding the wave of the masses, the market will teach me a lesson by dropping me on my ear.
If I'm sitting quietly on shares doing my due dillegence/homework, I'll turn around and my guess was accurate over time. And patience gets a reward.
I think the time of high frequency trading is about spent and there are less and less opportunities to fight over scraps at the table. I think trading patterns will turn to long and deliberate plays. That's my gut. And I'm following it. It starts with companies I believe in. I don't put all my eggs in one basket. For as brutal a day it was, my portfolio went up by $16.73. Oh well. It wasn't much but it's only paper until I sell and the stories I've invested in haven't played themselves out. This being one of them.
I don't know if there will be a split. I only know that this is a small float that has acquired some pharmacies this year and they will have completed two 503B pharmacies sometime in the the first quarter of 2016, according to statements.
I'm just trying to project in my own estimation what the value is over the next year.
Some will say that splits are merely an accounting trick. But the increase in shares allows for greater liquidity to acquire companies; if that's the plan.
I think they will continue to seek to acquire assets that have value like they have previously. Analysts have a short term target of +11 dollars. I believe with the completion of the 503B facilities things will open up. If the purpose of a stock split is to have the liquidity to purchase undervalued assets to strengthen the bottom line, it's a great thing.
The 2014 Q3 10K was filed on November 12 last year. So there should be some reading material how the aquisitions and balance look this week. Good or bad, looking forward to it. Really believing in this. With such a small float, I think there will be a split after the 10K for Q1 2016 is released. I'm thinking they will need liquidity for additional acquisitions over the next year.
Not sure if you can see after hours chart but the last 10 minutes there were about 33,000 shares sold to drop it to 6.17 and then a large block buy of 43,133 shares right at 4PM. Looks like a limit order for 6.45 a share.
Looking at the hourly chart, did this get driven down so someone could buy 43,000 shares end of day? That was weird.
I've really been out of touch with the MJ sector for a while and check the popular tickers once in a while. I'm not sure this is the only one? But I always hang a hat here. It's flown under the radar.
I agree, somewhat. A lot of fluid big money is staking a claim privately because of banking and cash flow/no banks = no loans. And you could bring big tobacco into the conversation and the fact they are laying in wait. I've seen estimates of projected values in the industry of $35 billion by 2020.
With an 8 million market cap, and boots on the ground, ie, brick and mortar stores with a business model; I like the odds. Best of luck!
I agree. But there is press there which is something this sector is lacking.
Yup. Same goes for short positions.
NP. I've been buying and flipping sine the AFAI days but have been holding for a while now expecting a 15% tax bill after the election year. Not promoting a political agenda; just interpreting a candidate's platform, he is trying to appeal to the families of the incarcerated from cannabis and the youth vote. It doesn't seem like it but the relationship between over-imprisonment and marijuana will be a great talking point in politics this year.
Surprised no one's talking about this over here.
http://www.cnbc.com/2015/11/05/bernie-sanders-files-bill-to-legalize-marijuana.html
Did anyone else catch this story today? Still saying in the news. IMMY
https://www.inverse.com/article/7784-pharma-bro-martin-shkreli-will-go-before-the-u-s-senate-after-unapologetic-price-gouging
Nice to see volume return to a reasonable amount. Hopefully the sellers are out and we stabilize a bit.
Not worried near term. This is under short attack. They've made some enemies. I see nothing but consolidation for the next year.
http://finance.yahoo.com/echarts?s=IMMY+Interactive#{"range":"5y","allowChartStacking":true}
There was a piece published on marketwatch a few minutes ago regarding Valeant where the author names companies that turn up in a search for "pharmacy network" on the SEC site and Imprimis is named in the article. Because the Philidor story has gained so much attention, the story appears to have spooked some and I think there were many that were stopped out at $7.
Holding and averaging for the year. Too much upside long term.
Nice interview with IMMY CEO, Mark Baum.
http://stateofreform.com/commentary/opinion/2015/11/exclusive-mark-baums-disruptive-solution-to-the-drug-pricing-crisis-in-the-us/
Also, did a little research on Pharmedium, the compounding pharmacy acquired by Amerisourcebergen, for 2.6 bil and they operate a total of four 503B outsourcing pharmacies. Imprimis has stated they should have 2 operational in the first quarter 2016 in Texas and New Jersey.
A counterintuitive approach to the market is vital.
Good call on that. Saw your message as it happened. Hopefully this dip helps to get rid of the panic sellers and the institutions are buying up 100,000+ shares a day where they belong. If an investor is panic selling they may want to consider allowing a 3rd party to manage their money. They are probably better at it.
Through June 30th 17% of IMMY was owned by insitutions. With 1.6 million shares held by institutions, and a share float 4.6 million - there were 2.7 million shares available, at that time. I think those shares may be close to getting gobbled up considering more than half the float now has traded hands since last Friday. I'm curious to see the figures of institutional ownership reported after the 4th quarter closes with the volatility seen in the past week. I firmly believe anyone selling is handing their shares over to fat cats. That's fine because they will stabilize the volatility once every apple has dropped from the tree.
Have a great weekend! I'll do some digging and post some more if I find anything of value. But not pumping this cause I want cheap shares too and it looks like its just you and me here! More shares for us.